Agios Pharmaceuticals Inc
Agios Pharmaceuticals Inc (AGIO) Historical Volatility
AGIO's 30 day historical volatility is 84.97%, in the 76th percentile of readings over the past year. This is a high percentile, meaning Agios Pharmaceuticals Inc shares have swung far more than usual. AGIO's 30 day implied volatility sits at 44.59%, with an IV Rank of 1.59%, leaving IV 40.38 points below historical volatility. This means options are pricing in less movement than the stock has actually delivered, as of Nov 17, 2026.
Read more
Tracking AGIO historical volatility helps you see how much Agios Pharmaceuticals Inc's stock price has actually moved, giving you a baseline for whether option premiums look fair, cheap, or expensive. While implied volatility shows what the market expects, AGIO's HV, also known as realized volatility, shows what actually happened. Use our scanner to monitor AGIO 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of a stock's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. AGIO's 30 day historical volatility, or AGIO HV, is one of the most widely watched readings because it balances responsiveness with stability. Comparing AGIO's HV to its implied volatility reveals the volatility risk premium. When IV sits well above HV, options are pricing in more movement than the stock has actually delivered, giving option sellers an edge. When HV runs hot relative to IV, options are pricing in less movement than the stock has delivered, and buyers may be underpaying for it.
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Historical Volatility
Historical movement is elevated versus the past year. The stock has been unusually active.
As of Nov 17, 2026
As of Nov 17, 2026
As of Nov 17, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →